Latest News

e vials filled with clear liquid and a syringe
Biosimilar, Innovator Romiplostim Comparably Safe and Effective

July 10th 2023

Noninferiority and comparable safety and immunogenicity between biosimilar romiplostim (ENZ110) and innovator romiplostim (Nplate) were identified in patients with chronic immune thrombocytopenia.

red blood cells and white blood cells
Samsung Bioepis' Eculizumab Biosimilar Approved in Europe

May 31st 2023

globe next to stethoscope
EU, Brazil Advance Hematology, Oncology Biosimilars

April 12th 2023

woman receiving subcutaneous injection by a doctor
Review: 15 Years of Real-world Data Demonstrates Safety of Epoetin Alfa Biosimilar HX575

March 4th 2023

heart floating above a man's hands
Phase 1 Study Demonstrates Bioequivalence Between Enoxaparin Biosimilar vs Reference Product

September 10th 2022

Video Interviews
canadian flag on a mountain

More News

© 2023 MJH Life Sciences

All rights reserved.